Cytokinetics, Incorporated (CYTK)
USD 35.47
(-5.06%)
USD 35.47
(-5.06%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -526.24 Million USD | -30.73% |
| 2022 | -402.55 Million USD | -66.09% |
| 2021 | -242.37 Million USD | -47.67% |
| 2020 | -164.13 Million USD | -10.12% |
| 2019 | -149.05 Million USD | -40.23% |
| 2018 | -106.28 Million USD | 16.83% |
| 2017 | -127.79 Million USD | -876.7% |
| 2016 | 16.45 Million USD | 143.87% |
| 2015 | -37.5 Million USD | -156.05% |
| 2014 | -14.64 Million USD | 56.56% |
| 2013 | -33.71 Million USD | 13.58% |
| 2012 | -39.01 Million USD | 18.48% |
| 2011 | -47.86 Million USD | 2.9% |
| 2010 | -49.28 Million USD | -300.81% |
| 2009 | 24.54 Million USD | 143.54% |
| 2008 | -56.37 Million USD | -15.3% |
| 2007 | -48.89 Million USD | 14.39% |
| 2006 | -57.11 Million USD | -35.18% |
| 2005 | -42.25 Million USD | -13.59% |
| 2004 | -37.19 Million USD | -13.81% |
| 2003 | -32.68 Million USD | -41.62% |
| 2002 | -23.08 Million USD | -45.39% |
| 2001 | -15.87 Million USD | -21.37% |
| 2000 | -13.07 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -135.64 Million USD | 0.92% |
| 2024 Q2 | -143.31 Million USD | -5.66% |
| 2023 Q2 | -128.63 Million USD | 0.62% |
| 2023 Q1 | -129.44 Million USD | 1.54% |
| 2023 Q4 | -136.89 Million USD | -5.77% |
| 2023 FY | -526.24 Million USD | -30.73% |
| 2023 Q3 | -129.42 Million USD | -0.61% |
| 2022 Q3 | -176.17 Million USD | -512.46% |
| 2022 Q4 | -131.46 Million USD | 25.38% |
| 2022 Q1 | -101.03 Million USD | -230.5% |
| 2022 FY | -402.55 Million USD | -66.09% |
| 2022 Q2 | -28.76 Million USD | 71.53% |
| 2021 Q2 | -61.55 Million USD | -30.68% |
| 2021 Q3 | -76.08 Million USD | -23.61% |
| 2021 Q4 | -30.57 Million USD | 59.82% |
| 2021 FY | -242.37 Million USD | -47.67% |
| 2021 Q1 | -47.1 Million USD | -7.23% |
| 2020 Q2 | -40.78 Million USD | -3.49% |
| 2020 Q3 | -3.17 Million USD | 92.21% |
| 2020 FY | -164.13 Million USD | -10.12% |
| 2020 Q4 | -43.93 Million USD | -1283.62% |
| 2020 Q1 | -39.4 Million USD | -28.61% |
| 2019 Q4 | -30.64 Million USD | -3.61% |
| 2019 Q1 | -29.36 Million USD | -10.94% |
| 2019 FY | -149.05 Million USD | -40.23% |
| 2019 Q2 | -32.11 Million USD | -9.35% |
| 2019 Q3 | -29.57 Million USD | 7.91% |
| 2018 Q1 | -30.28 Million USD | 25.2% |
| 2018 Q2 | -27.52 Million USD | 9.11% |
| 2018 Q3 | -22.01 Million USD | 20.01% |
| 2018 Q4 | -26.46 Million USD | -20.22% |
| 2018 FY | -106.28 Million USD | 16.83% |
| 2017 Q2 | -29.08 Million USD | -12.43% |
| 2017 FY | -127.79 Million USD | -876.7% |
| 2017 Q3 | -32.35 Million USD | -11.27% |
| 2017 Q1 | -25.86 Million USD | -461.42% |
| 2017 Q4 | -40.48 Million USD | -25.12% |
| 2016 Q2 | -11.61 Million USD | 6.78% |
| 2016 Q1 | -12.45 Million USD | -34.96% |
| 2016 FY | 16.45 Million USD | 143.87% |
| 2016 Q3 | 31.88 Million USD | 374.63% |
| 2016 Q4 | 7.15 Million USD | -77.56% |
| 2015 Q4 | -9.22 Million USD | -4.29% |
| 2015 FY | -37.5 Million USD | -156.05% |
| 2015 Q3 | -8.84 Million USD | 16.13% |
| 2015 Q2 | -10.55 Million USD | -18.92% |
| 2015 Q1 | -8.87 Million USD | -205.08% |
| 2014 Q3 | -5.97 Million USD | 28.7% |
| 2014 Q4 | 8.44 Million USD | 241.4% |
| 2014 Q1 | -8.74 Million USD | -233.88% |
| 2014 FY | -14.64 Million USD | 56.56% |
| 2014 Q2 | -8.37 Million USD | 4.23% |
| 2013 Q3 | -12.58 Million USD | 16.31% |
| 2013 FY | -33.71 Million USD | 13.58% |
| 2013 Q4 | 6.53 Million USD | 151.88% |
| 2013 Q2 | -15.04 Million USD | -19.19% |
| 2013 Q1 | -12.61 Million USD | -24.94% |
| 2012 Q3 | -10.04 Million USD | -12.31% |
| 2012 Q4 | -10.1 Million USD | -0.56% |
| 2012 FY | -39.01 Million USD | 18.48% |
| 2012 Q1 | -9.92 Million USD | 16.42% |
| 2012 Q2 | -8.94 Million USD | 9.92% |
| 2011 Q1 | -11.71 Million USD | -0.85% |
| 2011 Q2 | -13.63 Million USD | -16.39% |
| 2011 Q3 | -10.63 Million USD | 21.96% |
| 2011 Q4 | -11.87 Million USD | -11.65% |
| 2011 FY | -47.86 Million USD | 2.9% |
| 2010 Q4 | -11.61 Million USD | 5.9% |
| 2010 FY | -49.28 Million USD | -300.81% |
| 2010 Q1 | -12.18 Million USD | 2.71% |
| 2010 Q2 | -13.14 Million USD | -7.83% |
| 2010 Q3 | -12.34 Million USD | 6.11% |
| 2009 Q3 | -8.2 Million USD | -114.66% |
| 2009 Q4 | -12.52 Million USD | -52.76% |
| 2009 FY | 24.54 Million USD | 143.54% |
| 2009 Q1 | -10.68 Million USD | 1.58% |
| 2009 Q2 | 55.95 Million USD | 623.72% |
| 2008 Q3 | -16.25 Million USD | -5.83% |
| 2008 Q1 | -13.89 Million USD | -4.85% |
| 2008 FY | -56.37 Million USD | -15.3% |
| 2008 Q4 | -10.85 Million USD | 33.23% |
| 2008 Q2 | -15.36 Million USD | -10.57% |
| 2007 FY | -48.89 Million USD | 14.39% |
| 2007 Q4 | -13.25 Million USD | -17.06% |
| 2007 Q3 | -11.32 Million USD | 10.35% |
| 2007 Q2 | -12.62 Million USD | -8.01% |
| 2007 Q1 | -11.69 Million USD | 26.68% |
| 2006 Q1 | -12.46 Million USD | -12.48% |
| 2006 Q3 | -14.92 Million USD | -8.23% |
| 2006 Q4 | -15.94 Million USD | -6.88% |
| 2006 FY | -57.11 Million USD | -35.18% |
| 2006 Q2 | -13.78 Million USD | -10.61% |
| 2005 Q2 | -10.54 Million USD | -0.09% |
| 2005 Q3 | -10.1 Million USD | 4.17% |
| 2005 FY | -42.25 Million USD | -13.59% |
| 2005 Q4 | -11.08 Million USD | -9.7% |
| 2005 Q1 | -10.53 Million USD | 10.91% |
| 2004 Q2 | -9.23 Million USD | -55.61% |
| 2004 Q3 | -10.21 Million USD | -10.67% |
| 2004 Q1 | -5.93 Million USD | 27.4% |
| 2004 Q4 | -11.82 Million USD | -15.7% |
| 2004 FY | -37.19 Million USD | -13.81% |
| 2003 Q1 | -7.13 Million USD | 0.0% |
| 2003 FY | -32.68 Million USD | -41.62% |
| 2003 Q4 | -8.17 Million USD | 0.0% |
| 2003 Q3 | -8.17 Million USD | -5.64% |
| 2003 Q2 | -7.73 Million USD | -8.49% |
| 2002 FY | -23.08 Million USD | -45.39% |
| 2001 FY | -15.87 Million USD | -21.37% |
| 2000 FY | -13.07 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -259.461% |
| Alkermes plc | 355.75 Million USD | 247.922% |
| Agenus Inc. | -245.76 Million USD | -114.128% |
| Aptorum Group Limited | -2.82 Million USD | -18530.434% |
| Ardelyx, Inc. | -66.06 Million USD | -696.531% |
| Dyadic International, Inc. | -6.79 Million USD | -7644.052% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -56122.65% |
| Lantern Pharma Inc. | -15.96 Million USD | -3196.951% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -2665.501% |
| Novavax, Inc. | -545.06 Million USD | 3.452% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -802.757% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -613.164% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -2737.492% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -5169.818% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -792.201% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -40.846% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2062.117% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1309.33% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -219.761% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -617.472% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2493.485% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -745.304% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1519.96% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -297.186% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -19.535% |
| AlloVir, Inc. | -190.41 Million USD | -176.363% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -156.36% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1749.585% |
| Bicycle Therapeutics plc | -180.66 Million USD | -191.283% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -193.904% |
| ChromaDex Corporation | -4.93 Million USD | -10557.027% |
| Chimerix, Inc. | -82.09 Million USD | -541.018% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1079.832% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -415.572% |
| CRISPR Therapeutics AG | -153.61 Million USD | -242.584% |
| Precision BioSciences, Inc. | -61.31 Million USD | -758.207% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -227.006% |
| Fortress Biotech, Inc. | -60.63 Million USD | -767.86% |
| Fortress Biotech, Inc. | -60.63 Million USD | -767.86% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -545.065% |
| ImmuCell Corporation | -5.77 Million USD | -9013.085% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -365.863% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3311.399% |
| Incyte Corporation | 597.59 Million USD | 188.06% |
| Innoviva, Inc. | 179.72 Million USD | 392.81% |
| IO Biotech, Inc. | -86.08 Million USD | -511.322% |
| Jaguar Health, Inc. | -41.3 Million USD | -1174.199% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -243.968% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1109.019% |
| ContextLogic Inc. | -317 Million USD | -66.008% |
| MiMedx Group, Inc. | 67.43 Million USD | 880.326% |
| MEI Pharma, Inc. | 17.77 Million USD | 3060.085% |
| NextCure, Inc. | -62.72 Million USD | -738.997% |
| Onconetix, Inc. | -37.4 Million USD | -1306.705% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1232.972% |
| Opthea Limited | -220.24 Million USD | -138.939% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -928.643% |
| Vaxcyte, Inc. | -402.26 Million USD | -30.82% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1125.471% |
| Precigen, Inc. | -95.9 Million USD | -448.72% |
| Pharming Group N.V. | -10.54 Million USD | -4889.041% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -161.044% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -2044.171% |
| PureTech Health plc | -65.69 Million USD | -701.017% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1997.342% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -147.971% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2062.117% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -104.104% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1832.021% |
| Acelyrin, Inc. | -381.64 Million USD | -37.89% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -4195523.108% |
| Summit Therapeutics Inc. | -614.92 Million USD | 14.422% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1443.192% |
| Senti Biosciences, Inc. | -92.91 Million USD | -466.347% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -402.626% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1051.418% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1397.564% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -3925.776% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -7772.012% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1692.262% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -6090.378% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -815.0% |
| Seer, Inc. | -86.27 Million USD | -509.947% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -685.497% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -700.189% |
| ESSA Pharma Inc. | -26.58 Million USD | -1879.675% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1326.158% |
| GT Biopharma, Inc. | -7.59 Million USD | -6826.997% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -118.032% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -913.469% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 836.933% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -866.969% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -971.344% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -5190.083% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 8.135% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -14566.778% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -930.679% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -114.273% |
| Aptose Biosciences Inc. | -51.2 Million USD | -927.68% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -435.356% |
| Soligenix, Inc. | -6.14 Million USD | -8469.73% |
| Century Therapeutics, Inc. | -136.67 Million USD | -285.039% |
| Kura Oncology, Inc. | -152.63 Million USD | -244.782% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -489.841% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -4893.775% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 93163.116% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -92385.764% |
| Autolus Therapeutics plc | -208.38 Million USD | -152.537% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -631.931% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -643.335% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2328.669% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -133.627% |
| GRI Bio, Inc. | -13.03 Million USD | -3936.542% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -12627.877% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -324.103% |
| IGM Biosciences, Inc. | -246.41 Million USD | -113.559% |
| INmune Bio, Inc. | -30 Million USD | -1653.679% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -375.985% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1147.207% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3196.926% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -3231.716% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -781.702% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -420.174% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -90.581% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -121.211% |
| Verastem, Inc. | -87.36 Million USD | -502.337% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -871.145% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -226.179% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -351.1% |
| Histogen Inc. | -10.62 Million USD | -4854.75% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -3583.439% |
| Surrozen, Inc. | -43.04 Million USD | -1122.629% |
| Organovo Holdings, Inc. | -14.67 Million USD | -3486.967% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -10244.82% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -905.454% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -1983.062% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1853.538% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -6196.98% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -248.31% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -975.591% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1670.375% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -4951.439% |
| Apollomics, Inc. | -172.6 Million USD | -204.89% |
| Amarin Corporation plc | -59.11 Million USD | -790.249% |
| Mesoblast Limited | -87.95 Million USD | -498.304% |
| Turnstone Biologics Corp. | -55.2 Million USD | -853.341% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -258.082% |
| Synaptogenix, Inc. | -6.03 Million USD | -8614.808% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -3146.816% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -574.499% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10882.943% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -6163.172% |
| Exelixis, Inc. | 207.76 Million USD | 353.288% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1223.551% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -265.579% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 0.451% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4223.388% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -6651.314% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1611.418% |
| Gritstone bio, Inc. | -138.49 Million USD | -279.987% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -716.325% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -13056.264% |
| Avid Bioservices, Inc. | -140.75 Million USD | -273.878% |
| Insmed Incorporated | -749.56 Million USD | 29.794% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -3364.523% |
| MediWound Ltd. | -6.71 Million USD | -7735.676% |
| OmniAb, Inc. | -50.61 Million USD | -939.618% |
| Alector, Inc. | -130.39 Million USD | -303.589% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -362.738% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -914.994% |
| Zai Lab Limited | -334.62 Million USD | -57.266% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -62.428% |
| Aura Biosciences, Inc. | -76.4 Million USD | -588.729% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -124.285% |
| Immunic, Inc. | -93.61 Million USD | -462.154% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -287.249% |
| Veracyte, Inc. | -74.4 Million USD | -607.279% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -6756.108% |
| FibroGen, Inc. | -284.23 Million USD | -85.146% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1906.115% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -7415.742% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -2694.311% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 226.857% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2233.159% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1168.06% |
| TG Therapeutics, Inc. | 12.67 Million USD | 4252.809% |
| Galecto, Inc. | -38.34 Million USD | -1272.25% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -2689.378% |
| Fortrea Holdings Inc. | -3.4 Million USD | -15377.765% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -315.53% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -2922.48% |
| XBiotech Inc. | -24.55 Million USD | -2042.949% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -716.325% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -739.572% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -434.66% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2355.985% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -853.461% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 13.253% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -670.997% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -924205.336% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -132.297% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2263.281% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -139.518% |
| NexImmune, Inc. | -32.34 Million USD | -1527.002% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -9854.349% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -3646.604% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 113.311% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -2072.677% |
| Scopus BioPharma Inc. | -11.6 Million USD | -4432.746% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -350.559% |
| Ainos, Inc. | -13.77 Million USD | -3721.518% |
| Pluri Inc. | -20.88 Million USD | -2419.36% |
| Prothena Corporation plc | -147.02 Million USD | -257.921% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -362.14% |
| Celularity Inc. | -196.29 Million USD | -168.088% |
| Rallybio Corporation | -74.56 Million USD | -605.761% |
| Cue Biopharma, Inc. | -50.73 Million USD | -937.281% |
| MeiraGTx Holdings plc | -84.02 Million USD | -526.28% |
| Omeros Corporation | -117.81 Million USD | -346.677% |
| Humacyte, Inc. | -110.77 Million USD | -375.052% |
| Immunocore Holdings plc | -55.28 Million USD | -851.84% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -2826.179% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -2194.902% |
| Blueprint Medicines Corporation | -506.98 Million USD | -3.799% |
| CalciMedica, Inc. | -34.35 Million USD | -1431.694% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -677.605% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -272.154% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -217.418% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -85.785% |
| Pulmatrix, Inc. | -14.12 Million USD | -3626.677% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1395.224% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -536.806% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -9.363% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -401.801% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1359.154% |
| Nutriband Inc. | -5.48 Million USD | -9493.69% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1201.94% |
| Vor Biopharma Inc. | -117.86 Million USD | -346.488% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 112.101% |
| Evogene Ltd. | -23.87 Million USD | -2103.794% |
| ProKidney Corp. | -35.46 Million USD | -1383.715% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -339.404% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -6607.684% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 18.184% |
| CorMedix Inc. | -46.33 Million USD | -1035.634% |
| BioLineRx Ltd. | -60.61 Million USD | -768.189% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -417.224% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1181.459% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1208.284% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -552.502% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -596.818% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -80.103% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1787.803% |
| MediciNova, Inc. | -8.57 Million USD | -6039.451% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -326.879% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6182.135% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1926.606% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -119.967% |
| Biomea Fusion, Inc. | -117.25 Million USD | -348.803% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 16.016% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1685.936% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -243.587% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -151.358% |
| Absci Corporation | -110.56 Million USD | -375.955% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1645.42% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -421.876% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -123.044% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 3836.467% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -172.719% |
| Allakos Inc. | -185.7 Million USD | -183.382% |
| Imunon, Inc. | -19.51 Million USD | -2596.616% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -440.652% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 595.802% |
| BioAtla, Inc. | -123.46 Million USD | -326.24% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4223.388% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -3173.069% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -60.801% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1324.244% |
| XOMA Corporation | -40.83 Million USD | -1188.834% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -416.584% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -344.039% |
| aTyr Pharma, Inc. | -50.38 Million USD | -944.363% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -500.194% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -246.763% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -121.358% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1398.46% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -6403.311% |
| Akari Therapeutics, Plc | -10 Million USD | -5158.233% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -781547.234% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 286.88% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7795.754% |
| UroGen Pharma Ltd. | -102.24 Million USD | -414.694% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -392.77% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -6666.511% |
| Orgenesis Inc. | -55.36 Million USD | -850.568% |
| Entera Bio Ltd. | -8.88 Million USD | -5820.171% |
| GH Research PLC | -35.58 Million USD | -1378.753% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2425.163% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -580.007% |
| Xencor, Inc. | -126.08 Million USD | -317.366% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -13874.659% |
| Replimune Group, Inc. | -215.79 Million USD | -143.864% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2374.517% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 21074.253% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7795.754% |
| Portage Biotech Inc. | -75.33 Million USD | -598.501% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6182.135% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -444.456% |
| OncoCyte Corporation | -27.78 Million USD | -1794.259% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -3822.156% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -4631.763% |
| Purple Biotech Ltd. | -19.88 Million USD | -2547.103% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -7397.421% |
| scPharmaceuticals Inc. | -54.81 Million USD | -860.124% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -2906.054% |
| HilleVax, Inc. | -123.56 Million USD | -325.881% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -5106.728% |
| Tharimmune, Inc. | -9.31 Million USD | -5546.944% |
| Genprex, Inc. | -30.86 Million USD | -1605.237% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -123.056% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1648.668% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -29431.089% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -9836.603% |
| OKYO Pharma Limited | -16.82 Thousand USD | -3127564.86% |
| Savara Inc. | -54.69 Million USD | -862.09% |
| Curis, Inc. | -47.41 Million USD | -1009.915% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1644.76% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3307.193% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -9349.524% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1665.031% |
| BeiGene, Ltd. | -881.7 Million USD | 40.315% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2371.325% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -20.597% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -566.511% |
| Erasca, Inc. | -125.04 Million USD | -320.854% |
| bluebird bio, Inc. | -211.91 Million USD | -148.33% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -10423.834% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 413.904% |
| DBV Technologies S.A. | -72.72 Million USD | -623.598% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -10423.834% |
| Moderna, Inc. | -4.71 Billion USD | 88.837% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1210.466% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -9142.079% |
| Molecular Templates, Inc. | -8.12 Million USD | -6377.646% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -771.438% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -372.396% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -288.797% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -998.195% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -272.091% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -173.501% |
| MacroGenics, Inc. | -9.05 Million USD | -5709.715% |
| RenovoRx, Inc. | -10.23 Million USD | -5043.12% |
| Adicet Bio, Inc. | -142.65 Million USD | -268.885% |
| Prime Medicine, Inc. | -198.13 Million USD | -165.601% |
| Aditxt, Inc. | -32.38 Million USD | -1525.171% |
| Adagene Inc. | -18.94 Million USD | -2677.545% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7097.264% |
| Quantum-Si incorporated | -95.96 Million USD | -448.399% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -342.114% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3509.908% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 497.676% |
| SciSparc Ltd. | -5.12 Million USD | -10174.19% |
| Vericel Corporation | -3.18 Million USD | -16438.152% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -437510.391% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1653.834% |
| Generation Bio Co. | -126.61 Million USD | -315.635% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -621.96% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -538.32% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -100.749% |
| Invivyd, Inc. | -198.64 Million USD | -164.919% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -53.885% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -5958.131% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2407.48% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -5229.593% |
| 2seventy bio, Inc. | -217.57 Million USD | -141.873% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1763.536% |
| Clene Inc. | -49.5 Million USD | -963.033% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2261.158% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -964.539% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1926.606% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -60.408% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1517.077% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2416.215% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -432.68% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -603.968% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -227.256% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 14.44% |
| Evaxion Biotech A/S | -22.12 Million USD | -2278.504% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -551.808% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -163.033% |
| Trevena, Inc. | -40.28 Million USD | -1206.173% |
| Surrozen, Inc. | -43.04 Million USD | -1122.629% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -661.194% |
| Cingulate Inc. | -23.53 Million USD | -2136.011% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -7513.484% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1220.231% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -6724.878% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -483.354% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -758.669% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -784.399% |
| Clearmind Medicine Inc. | -11.95 Million USD | -4301.862% |
| Kronos Bio, Inc. | -112.67 Million USD | -367.054% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -660.501% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -20748964.556% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -512.66% |
| Statera Biopharma, Inc. | -174.4 Million USD | -201.731% |
| ImmunityBio, Inc. | -583.19 Million USD | 9.765% |
| Korro Bio, Inc. | -81.17 Million USD | -548.307% |
| Kineta, Inc. | -14.09 Million USD | -3632.492% |
| BioVie Inc. | -32.12 Million USD | -1538.341% |
| Codexis, Inc. | -76.24 Million USD | -590.247% |
| Celularity Inc. | -196.29 Million USD | -168.088% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -145.302% |
| Celcuity Inc. | -63.77 Million USD | -725.104% |
| Virax Biolabs Group Limited | -6.73 Million USD | -7715.269% |
| Cibus, Inc. | -267.62 Million USD | -96.633% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1204.974% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1369.504% |
| IN8bio, Inc. | -30 Million USD | -1653.737% |
| Kodiak Sciences Inc. | -260.49 Million USD | -102.02% |
| Annexon, Inc. | -134.23 Million USD | -292.026% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -349.148% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -759.483% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1568.286% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -43.67% |
| Eyenovia, Inc. | -27.26 Million USD | -1830.385% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2537.33% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -98263.364% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -588.765% |
| Arcellx, Inc. | -70.69 Million USD | -644.439% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1169.863% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -293.259% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1651.986% |
| Moolec Science SA | -51.78 Million USD | -916.133% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -904.839% |
| Geron Corporation | -184.12 Million USD | -185.805% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1153.738% |
| Royalty Pharma plc | 1.13 Billion USD | 146.372% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -287.069% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -5818.305% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2377.231% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -206.544% |
| Humacyte, Inc. | -110.77 Million USD | -375.052% |
| Structure Therapeutics Inc. | -89.62 Million USD | -487.195% |
| 89bio, Inc. | -142.18 Million USD | -270.102% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -663.115% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -4971.254% |
| Genelux Corporation | -28.29 Million USD | -1759.717% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1710.576% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -197.113% |
| Notable Labs, Ltd. | -11.26 Million USD | -4571.911% |
| Liquidia Corporation | -78.5 Million USD | -570.357% |
| Mustang Bio, Inc. | -51.6 Million USD | -919.813% |
| Immunovant, Inc. | -259.33 Million USD | -102.92% |
| Quantum-Si incorporated | -95.96 Million USD | -448.399% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -622.376% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -2615.257% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -448.228% |
| Acasti Pharma Inc. | -12.85 Million USD | -3994.328% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2243.251% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3196.926% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -188.522% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -12133.917% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -4120.08% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1684.422% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1249.759% |
| PepGen Inc. | -78.62 Million USD | -569.3% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1667.758% |
| United Therapeutics Corporation | 984.8 Million USD | 153.437% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2264.079% |
| Solid Biosciences Inc. | -96.01 Million USD | -448.085% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10882.943% |
| Immuneering Corporation | -53.47 Million USD | -884.156% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -10244.82% |
| Silo Pharma, Inc. | -3.7 Million USD | -14120.186% |
| Belite Bio, Inc | -31.63 Million USD | -1563.644% |
| XOMA Corporation | -40.83 Million USD | -1188.834% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -867.983% |
| Bionomics Limited | -15.49 Billion USD | 96.603% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -526.593% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1704.863% |
| uniQure N.V. | -308.47 Million USD | -70.594% |
| Cassava Sciences, Inc. | -97.21 Million USD | -441.309% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7097.264% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -326.35% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1571.89% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -6316.277% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1710.389% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -98263.364% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1906.115% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -3092.26% |
| Altimmune, Inc. | -88.44 Million USD | -494.982% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -247.163% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1704.863% |
| Compugen Ltd. | -18.75 Million USD | -2706.036% |
| Peak Bio, Inc. | -1259.26 USD | -41789840.124% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1042.791% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2319.401% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -55.33% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -534.381% |
| Zura Bio Limited | -60.36 Million USD | -771.842% |
| PolyPid Ltd. | -23.86 Million USD | -2105.087% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -3245.055% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -534.381% |
| Instil Bio, Inc. | -156.08 Million USD | -237.148% |
| argenx SE | -295.05 Million USD | -78.356% |
| Immunome, Inc. | -106.8 Million USD | -392.71% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1138.396% |
| Verona Pharma plc | -54.36 Million USD | -867.912% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -426.681% |
| Shattuck Labs, Inc. | -87.29 Million USD | -502.813% |
| CervoMed Inc. | -2.17 Million USD | -24129.962% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -322.174% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -3851.968% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1108.229% |
| Moolec Science SA | -51.78 Million USD | -916.133% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -3043227.649% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -289.472% |
| AnaptysBio, Inc. | -163.61 Million USD | -221.628% |
| Design Therapeutics, Inc. | -66.86 Million USD | -687.06% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -546.38% |
| NeurAxis, Inc. | -14.62 Million USD | -3497.836% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1289.166% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1446.23% |
| Achilles Therapeutics plc | -69.66 Million USD | -655.392% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -426.681% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2539.785% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 17590.22% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -20748964.556% |
| Nutriband Inc. | -5.48 Million USD | -9493.69% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -422.601% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -982.651% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -582.627% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1449.143% |
| MoonLake Immunotherapeutics | -36 Million USD | -1361.494% |
| Palisade Bio, Inc. | -12.3 Million USD | -4178.407% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1149.274% |
| Beam Therapeutics Inc. | -132.52 Million USD | -297.084% |
| Neurogene Inc. | -36.31 Million USD | -1349.029% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -222.029% |
| AEON Biopharma, Inc. | -52.55 Million USD | -901.301% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -436.179% |
| Sesen Bio, Inc. | -19.88 Million USD | -2546.57% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -635.142% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -4105.277% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -18.514% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -371.689% |
| Athira Pharma, Inc. | -117.67 Million USD | -347.213% |
| Vaccinex, Inc. | -20.25 Million USD | -2498.607% |
| HCW Biologics Inc. | -24.99 Million USD | -2005.458% |
| XOMA Corporation | -40.83 Million USD | -1188.834% |
| Nektar Therapeutics | -276.05 Million USD | -90.629% |
| Arvinas, Inc. | -367.3 Million USD | -43.274% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -781547.234% |
| Merus N.V. | -154.93 Million USD | -239.646% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -440.136% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1576.737% |
| Rezolute, Inc. | -68.45 Million USD | -668.7% |
| Clene Inc. | -49.5 Million USD | -963.033% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3311.969% |
| BeyondSpring Inc. | -21.02 Million USD | -2402.825% |
| Synlogic, Inc. | -57.28 Million USD | -818.69% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -4321.847% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4760.927% |
| Peak Bio, Inc. | -1259.26 USD | -41789840.124% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1308.274% |
| Krystal Biotech, Inc. | 10.93 Million USD | 4913.794% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -267.748% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -61.869% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -11293.115% |
| MannKind Corporation | -11.93 Million USD | -4308.142% |
| Ikena Oncology, Inc. | -68.16 Million USD | -672.004% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2404.135% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -466.262% |
| Gossamer Bio, Inc. | -179.81 Million USD | -192.655% |
| CohBar, Inc. | -11.96 Million USD | -4299.254% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1940.655% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1645.42% |
| Legend Biotech Corporation | -518.25 Million USD | -1.542% |
| Mural Oncology plc | -207.44 Million USD | -153.676% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -323.997% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -2777.266% |
| Disc Medicine, Inc. | -76.42 Million USD | -588.54% |
| Champions Oncology, Inc. | -7.27 Million USD | -7132.6% |
| REGENXBIO Inc. | -263.49 Million USD | -99.718% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -4858.45% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -1007.765% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1285.454% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -425.388% |
| Vaxart, Inc. | -82.46 Million USD | -538.142% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 157769.963% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1301.728% |
| Cellectis S.A. | -101.05 Million USD | -420.729% |
| Longeveron Inc. | -21.41 Million USD | -2357.591% |
| Repare Therapeutics Inc. | -93.79 Million USD | -461.052% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 1.816% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -639.429% |
| Revolution Medicines, Inc. | -436.36 Million USD | -20.597% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -7908.583% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1607.254% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -659.009% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -712.958% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -5263.816% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 114.539% |
| Denali Therapeutics Inc. | -145.22 Million USD | -262.367% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -437510.391% |
| Veru Inc. | -93.15 Million USD | -464.926% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1846.961% |
| Cingulate Inc. | -23.53 Million USD | -2136.011% |
| Passage Bio, Inc. | -102.06 Million USD | -415.612% |
| Context Therapeutics Inc. | -23.96 Million USD | -2095.958% |
| Exicure, Inc. | -16.91 Million USD | -3011.292% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -178.558% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1293.507% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -7986.949% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -184.952% |
| Nuvalent, Inc. | -126.21 Million USD | -316.929% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -4904.386% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -505.721% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1622.905% |
| OmniAb, Inc. | -50.61 Million USD | -939.618% |
| Anew Medical, Inc. | 1.34 Million USD | 39193.249% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -3179.801% |
| Lipocine Inc. | -16.35 Million USD | -3118.208% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -692.608% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -726.453% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1147.207% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -997.096% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -2553.643% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 2.815% |
| Ocugen, Inc. | -63.07 Million USD | -734.275% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -449.705% |
| Q32 Bio Inc. | -112.96 Million USD | -365.863% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -2960.982% |
| Alumis Inc. Common Stock | -154.99 Million USD | -239.528% |
| Equillium, Inc. | -13.33 Million USD | -3846.337% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -771.756% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -6488.067% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -2691.564% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -790.701% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -359.493% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -2763.453% |
| Dominari Holdings Inc. | -22.88 Million USD | -2199.816% |
| Edesa Biotech, Inc. | -8.37 Million USD | -6183.949% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2498.736% |
| Bio-Techne Corporation | 168.1 Million USD | 413.045% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -49.464% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 508.406% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -331.942% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1287.079% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -367.183% |
| Nkarta, Inc. | -117.5 Million USD | -347.863% |
| BioCardia, Inc. | -11.57 Million USD | -4447.956% |
| Iterum Therapeutics plc | -38.37 Million USD | -1271.463% |